Rsv vaccine pref3, recombinant Disease Interactions
There are 2 disease interactions with rsv vaccine pref3, recombinant.
RSV vaccine (applies to rsv vaccine pref3, recombinant) immunodeficiency
Moderate Potential Hazard, Moderate plausibility.
Immunocompromised individuals, including those receiving immunosuppressive therapy, may have a diminished immune response to the RSV vaccine.
References (3)
- (2024) "Product Information. Mresvia Prefilled Syringe (cvx 326) (RSV mRNA vaccine (cvx 326))." Moderna US, Inc
- (2024) "Product Information. Arexvy (RSV vaccine preF3, recombinant)." GlaxoSmithKline
- (2025) "Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant)." Pfizer U.S. Pharmaceuticals Group, STN 125769/388
RSV vaccine (applies to rsv vaccine pref3, recombinant) syncope
Moderate Potential Hazard, Moderate plausibility.
Syncope may occur in association with administration of injectable vaccines, including the RSV vaccine. Procedures should be in place to avoid injury from fainting, especially for patients who have previously fainted in association with an injection.
References (3)
- (2024) "Product Information. Mresvia Prefilled Syringe (cvx 326) (RSV mRNA vaccine (cvx 326))." Moderna US, Inc
- (2024) "Product Information. Arexvy (RSV vaccine preF3, recombinant)." GlaxoSmithKline
- (2025) "Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant)." Pfizer U.S. Pharmaceuticals Group, STN 125769/388
Switch to consumer interaction data
Rsv vaccine pref3, recombinant drug interactions
There are 298 drug interactions with rsv vaccine pref3, recombinant.
Report options
More about rsv vaccine pref3, recombinant
- rsv vaccine pref3, recombinant consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Arexvy
Arexvy is an RSV vaccine used to prevent severe Respiratory Syncytial Virus Vaccine (RSV) symptoms ...
Abrysvo
Abrysvo vaccine protects against LRTD (lower respiratory tract disease) caused by the Respiratory ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Beyfortus
Beyfortus is used to protect babies under 1 year of age from serious RSV lung infections. A ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
mRESVIA
mResvia is an RSV vaccine that may be used to protect adults aged 60 years and older against lower ...
Palivizumab
Palivizumab systemic is used for RSV, RSV Vaccination and Immunization
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Rsv vaccine, mrna
Rsv vaccine, mrna systemic is used for RSV, RSV Vaccination and Immunization
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
